[13 May 2013]
Products Affected - Description
Potassium phosphate injection, American Regent
3 mMol/mL, 5 mL vial (NDC 00517-2305-25)
3 mMol/mL, 15 mL vial (NDC 00517-2315-25)
3 mMol/mL, 50 mL vial (NDC 00517-2350-25)
Potassium phosphate injection, Hospira
3 mMol/mL, 15 mL vial (NDC 00409-7295-01)
Reason for the Shortage
- American Regent had temporarily suspended manufacture of most drug products including all potassium phosphate presentations in April, 2011.
- American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
- American Regent has issued a statement that all lots of potassium phosphate may contain glass particles and filters must be used. Do not use if there are visible glass particles and filter all other product.
- Hospira has potassium phosphate 15 mL vials on shortage due to manufacturing delays.
Available Products
No presentations are readily available.
Estimated Resupply Dates
- American Regent has potassium phosphate 3 mMol/mL 5 mL, 15 mL, and 50 mL vials on back order and the company cannot estimate a release date.
- Hospira has potassium phosphate 3 mMol/mL 15 mL vials on back order and the company estimates a release date of May, 2013.
Updated
May 13, 2013; April 1, 2013; March 18, 2013; February 20, 2013; February 4, 2013; January 30, 2013; December 31, 2012; December 10, 2012; November 15, 2012; September 17, 2012; July 17, 2012; May 24, 2012; May 1, 2012; March 27, 2012; February 10, 2012; January 3, 2012; December 9, 2011; November 22, 2011; November 10, 2011; October 11, 2011; September 27, 2011; August 23, 2011; August 1, 2011; July 29, 2011; July 26, 2011; July 22, 2011; June 23, 2011; May 6, 2011; April 29, 2011; April 12, 2011; March 29, 2011; February 25, 2011; February 4, 2011; January 10, 2011; December 27, 2010; December 17, 2010, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins